TLN1

Across TCGA pan-cancer cohorts, TLN1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of TLN1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where TLN1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TLN1 is over-expressed in tumor, although a few such as COAD and LSCC show the opposite, repressed pattern.

COAD, LSCC, and LUAD are the cancer types where TLN1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TLN1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−1.279	<.001	11	view →
LSCC	Female	All	−0.866	<.001	9	view →
LUAD	Female	II,III,IV	−0.743	<.001	9	view →
PDAC	Male	All	+0.618	<.001	7	view →
HNSC	All	III,IV	−0.161	<.001	6	view →
OV	All	All	−0.552	.003	2	view →
CCRCC	All	All	+0.081	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

TLN1–COAD

Open the COAD breakdown →